Calls Now Open

2026 Harrington Scholar-Innovator and 2026 Harrington Prize

You've just added:

Checkout Go to Cart

Frank Richardson, DVM, PhD, DABT

Frank Richardson, DVM, PhD, DABT

Frank Richardson, DVM, PhD, DABT has logged over 25 years in both large pharmaceutical and biotechnology drug development activities, including toxicologic assessment of drug candidates, biomarker development, and animal care and use. He has conducted all aspects of preclinical toxicology and biomarker development from discovery to product registration with emphasis on oncology and antiviral compounds.

Former Principal Toxicologist, Affygility Solutions

Former Principal Research Fellow in Toxicology and Molecular Markers, OSI Pharmaceuticals

Former Director of Toxicology Safety Assessment and Animal Facility, Gilead Pharmaceuticals

We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.